Asset 1

Gentest® Mast Cell Activation (MCA) Assay Service

Assess thrombocytopenia potential caused by drug candidate toxicity to megakaryocytes and platelets at various stages of development.

By utilizing our state-of-the-art technologies and expert knowledge, Discovery’s mast cell activation (MCA) assay service helps preclinical researchers identify compounds that could potentially reverse mast cell activation, as measured by CD63 expression.

Contact Us Today

Quick Links

Technologies

Development and Clinical
Trial Solutions